AnaptysBio, Inc. (ANAB)
45.78
+0.83
(+1.85%)
USD |
NASDAQ |
Dec 11, 16:00
45.78
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Cash from Investing (Quarterly): 103.28M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ovid Therapeutics, Inc. | 5.053M |
| Ionis Pharmaceuticals, Inc. | 91.34M |
| Vanda Pharmaceuticals, Inc. | 21.36M |
| CorMedix, Inc. | -291.32M |
| Verastem, Inc. | -8.279M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -27.36M |
| Cash from Financing (Quarterly) | -10.39M |
| Free Cash Flow | -145.42M |
| Free Cash Flow Per Share (Quarterly) | -0.9431 |
| Free Cash Flow to Equity (Quarterly) | -27.36M |
| Free Cash Flow to Firm (Quarterly) | -4.853M |
| Free Cash Flow Yield | -10.68% |